# Hangzhou Aiweike Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-aiweike-biotechnology

- Industry: Biotechnology
- Headquarters: Hangzhou, China
- Latest round: Series A (May 1, 2022)
- Investors on record: 5

## About

Established in 2022 and based in Hangzhou, China, Hangzhou Aiweike Biotechnology is a manufacturer of biological products, focusing on bio-based materials technology research and development, biomass energy technology services, and bio-chemical products technology research and development.

The company mainly develops and produces early tumor screening products, and also includes the development of bio-based material technology and the production of Class II medical devices.

## Funding rounds

- Series A, May 1, 2022 — Cathay Capital, GP Capital, Decheng Capital, Yushan Partners, Cui Capital

## Investors

- Cathay Capital — Series A
- GP Capital (https://capitalatlas.ai/funds/gp-capital) — Series A
- Decheng Capital (https://capitalatlas.ai/funds/decheng-capital) — Series A
- Yushan Partners (https://capitalatlas.ai/funds/yushan-partners) — Series A
- Cui Capital (https://capitalatlas.ai/funds/cui-capital) — Series A